The Children's Hospital of Philadelphia, Division of Neurology
Philadelphia, Pennsylvania, 19104, United States
NCT Number: NCT02229318
Subjects will be asked to substitute their usual vitamin and mineral supplement/s with FruitiVits for seven consecutive days.
Looking for future studies?
Notify Me4 year–9 year
All sexes
Interventional
Not applicable
Philadelphia, Pennsylvania, 19104, United States
The study will involve 12 subjects between 4 and 8 years of age, who routinely use comprehensive micronutrient supplementation as part of their dietary management.
Primary Hypothesis:
FruitiVits is an acceptable source of vitamin, mineral and trace elements for patients on a Ketogenic diet.
Secondary Hypothesis:
FruitiVits will be well accepted and tolerated when given orally to children on a Ketogenic diet.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Daily administration of FruitiVits dietary supplement
Time frame: Day 8 of trial
The study product was rated on a scale of 1-5:
Time frame: Day 8 of trial
Ease of preparation of FruitiVits was rated on a scale of 1-5:
Those who considered it not difficult to prepare and scored 1-3 on the scale: 11/11 patients
Vitaflo International, Ltd
Industry
A Taste and Acceptance Study of FruitiVits, for Use in the Dietary Management of Young Children Requiring Very Restrictive Diets Such as the Ketogenic Diet.
Acronym: FruitiVits
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01116700
Brain Diseases, Central Nervous System Diseases
San Francisco, California, United States
View Trial DetailsNCT01159431
Brain Diseases, Central Nervous System Diseases
Los Angeles, California, United States
View Trial DetailsNCT06352372
Autism Spectrum Disorder, Autistic Disorder
Phoenix, Arizona, United States
View Trial DetailsNCT04666610
Brain Diseases, Central Nervous System Diseases
Birmingham, Alabama, United States
View Trial Details